These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8466552

  • 1. Characterization of cannabidiol-mediated cytochrome P450 inactivation.
    Bornheim LM, Everhart ET, Li J, Correia MA.
    Biochem Pharmacol; 1993 Mar 24; 45(6):1323-31. PubMed ID: 8466552
    [Abstract] [Full Text] [Related]

  • 2. Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol.
    Bornheim LM, Everhart ET, Li J, Correia MA.
    Biochem Pharmacol; 1994 Jul 05; 48(1):161-71. PubMed ID: 8043019
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.
    Yamaori S, Ebisawa J, Okushima Y, Yamamoto I, Watanabe K.
    Life Sci; 2011 Apr 11; 88(15-16):730-6. PubMed ID: 21356216
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of hepatic microsomal cytochrome P450 by cannabidiol in adult male rats.
    Narimatsu S, Watanabe K, Matsunaga T, Yamamoto I, Imaoka S, Funae Y, Yoshimura H.
    Chem Pharm Bull (Tokyo); 1990 May 11; 38(5):1365-8. PubMed ID: 2393963
    [Abstract] [Full Text] [Related]

  • 6. Effects of two cannabinoids on hepatic microsomal cytochrome P-450.
    Watanabe K, Hamajima K, Narimatsu S, Yamamoto I, Yoshimura H.
    J Pharmacobiodyn; 1986 Jan 11; 9(1):39-45. PubMed ID: 3012058
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator.
    Bornheim LM, Grillo MP.
    Chem Res Toxicol; 1998 Oct 11; 11(10):1209-16. PubMed ID: 9778318
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol.
    Yamaori S, Okushima Y, Yamamoto I, Watanabe K.
    Chem Biol Interact; 2014 May 25; 215():62-8. PubMed ID: 24667653
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of cannabidiol on cytochrome P-450 isozymes.
    Bornheim LM, Correia MA.
    Biochem Pharmacol; 1989 Sep 01; 38(17):2789-94. PubMed ID: 2550010
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recent advances in the metabolism of cannabinoids.
    Yamamoto I, Watanabe K, Narimatsu S, Yoshimura H.
    Int J Biochem Cell Biol; 1995 Aug 01; 27(8):741-6. PubMed ID: 7584607
    [Abstract] [Full Text] [Related]

  • 18. Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes.
    Weber GF, Waxman DJ.
    Biochem Pharmacol; 1993 Apr 22; 45(8):1685-94. PubMed ID: 8484807
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inactivation of ethanol-inducible cytochrome P450 and other microsomal P450 isozymes by trans-4-hydroxy-2-nonenal, a major product of membrane lipid peroxidation.
    Bestervelt LL, Vaz AD, Coon MJ.
    Proc Natl Acad Sci U S A; 1995 Apr 25; 92(9):3764-8. PubMed ID: 7731980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.